CYTK CYTOKINETICS INC
Nasdaq · SEC CIK 1061983 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $52.26M 81 sales by 10 insiders
- Filings on record
- 559 since 2021-07-02, latest 2026-09-22 18:14
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Blum Robert I | Pres, CEO, Dir | — | $17.08M |
| Callos Andrew | EVP, Chief Commercial Off | — | $16.02M |
| Lee Sung | EVP, CFO | — | $5.70M |
| Malik Fady Ibraham | EVP Research, Development | — | $4.65M |
| Kaye Edward M. MD | Dir | — | $3.21M |
| HENDERSON JOHN T | Dir | — | $2.08M |
| WIERENGA WENDELL | Dir | — | $1.88M |
| PARSHALL B LYNNE | Dir | — | $1.36M |
| Landry Robert E | Dir | — | $146.8K |
| Harrington Robert Arthur | Dir | — | $143.6K |
Transactions 784
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-22 18:14 | 2026-09-22 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-09-22 18:14 | 2026-09-22 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $68.29 | -3,500 | 153.9K | -2% | -$239.0K |
| T | 2026-09-15 17:23 | 2026-09-15 | CYTK | Landry Robert E | Dir | S - Sale | $72.13 | -1,000 | 8,184 | -11% | -$72.1K |
| DT | 2026-09-15 17:20 | 2026-09-14 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $10.60 | +7,500 | 385.3K | +2% | +$79.5K |
| DT | 2026-09-15 17:20 | 2026-09-14 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $73.44 | -7,500 | 377.8K | -2% | -$550.8K |
| DMT | 2026-09-15 17:20 | 2026-09-14 | CYTK | Blum Robert I | Pres, CEO, Dir | G - Gift | $0.00 | -99.3K | 278.5K | -26% | $0 |
| DTI | 2026-09-15 17:20 | 2026-09-14 | CYTK | Blum Robert I | Pres, CEO, Dir | G - Gift | $0.00 | +97.9K | 97.9K | New | $0 |
| DTI | 2026-09-15 17:20 | 2026-09-15 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $69.33 | -97.9K | 0 | -100% | -$6.79M |
| T | 2026-09-11 19:12 | 2026-09-11 | CYTK | Landry Robert E | Dir | S - Sale | $74.66 | -1,000 | 9,184 | -10% | -$74.7K |
| DT | 2026-09-08 16:38 | 2026-09-08 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-09-08 16:38 | 2026-09-08 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $75.46 | -3,500 | 153.9K | -2% | -$264.1K |
| T | 2026-09-01 16:51 | 2026-09-01 | CYTK | PARSHALL B LYNNE | Dir | S - Sale | $71.48 | -5,000 | 10.8K | -32% | -$357.4K |
| DT | 2026-08-31 16:57 | 2026-08-31 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $23.26 | +10.0K | 68.6K | +17% | +$232.6K |
| DT | 2026-08-31 16:57 | 2026-08-31 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $70.24 | -10.0K | 58.6K | -15% | -$702.4K |
| DT | 2026-08-31 16:55 | 2026-08-31 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $10.60 | +7,500 | 385.3K | +2% | +$79.5K |
| DT | 2026-08-31 16:55 | 2026-08-31 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $70.24 | -7,500 | 377.8K | -2% | -$526.8K |
| DT | 2026-08-18 16:38 | 2026-08-18 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-08-18 16:38 | 2026-08-18 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $75.82 | -3,500 | 153.9K | -2% | -$265.4K |
| DT | 2026-08-10 17:11 | 2026-08-10 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $10.60 | +7,500 | 385.3K | +2% | +$79.5K |
| DT | 2026-08-10 17:11 | 2026-08-10 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $76.76 | -7,500 | 377.8K | -2% | -$575.7K |
| DT | 2026-07-30 16:26 | 2026-07-30 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $23.26 | +14.0K | 72.6K | +24% | +$325.6K |
| DT | 2026-07-30 16:26 | 2026-07-30 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $79.88 | -14.0K | 58.6K | -19% | -$1.12M |
| DT | 2026-07-27 16:33 | 2026-07-27 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $10.60 | +7,500 | 385.3K | +2% | +$79.5K |
| DT | 2026-07-27 16:33 | 2026-07-27 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $80.87 | -7,500 | 377.8K | -2% | -$606.5K |
| DT | 2026-07-23 16:09 | 2026-07-21 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-07-23 16:09 | 2026-07-21 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $80.59 | -3,500 | 153.9K | -2% | -$282.1K |
| 2026-07-16 16:35 | 2026-07-15 | CYTK | Wysenski Nancy | Dir | A - Grant | $82.62 | +75 | 34.0K | +0.2% | +$6,196 | |
| 2026-07-16 16:34 | 2026-07-15 | CYTK | WIERENGA WENDELL | Dir | A - Grant | $82.62 | +75 | 35.6K | +0.2% | +$6,196 | |
| 2026-07-16 16:32 | 2026-07-15 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $82.62 | +151 | 10.4K | +1% | +$12.5K | |
| 2026-07-16 16:31 | 2026-07-15 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $82.62 | +272 | 78.4K | +0.3% | +$22.5K | |
| 2026-07-16 16:29 | 2026-07-15 | CYTK | Harrington Robert Arthur | Dir | A - Grant | $82.62 | +151 | 21.9K | +0.7% | +$12.5K | |
| 2026-07-16 16:28 | 2026-07-15 | CYTK | Daly James M | Dir | A - Grant | $82.62 | +151 | 3,390 | +5% | +$12.5K | |
| DMT | 2026-07-14 15:34 | 2026-07-13 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $82.02 | -7,500 | 377.8K | -2% | -$615.1K |
| DT | 2026-07-14 15:34 | 2026-07-13 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $10.60 | +7,490 | 385.3K | +2% | +$79.4K |
| DT | 2026-07-07 17:06 | 2026-07-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-07-07 17:06 | 2026-07-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $86.62 | -3,500 | 153.9K | -2% | -$303.2K |
| T | 2026-07-02 17:20 | 2026-07-01 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale | $84.92 | -7,500 | 377.8K | -2% | -$636.9K |
| DT | 2026-07-02 17:19 | 2026-07-01 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $23.26 | +15.0K | 73.6K | +26% | +$348.9K |
| DT | 2026-07-02 17:19 | 2026-07-01 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $85.80 | -15.0K | 58.6K | -20% | -$1.29M |
| DT | 2026-07-02 17:17 | 2026-07-01 | CYTK | Lee Sung | EVP, CFO | M - OptEx | $48.51 | +1,112 | 64.3K | +2% | +$53.9K |
| DT | 2026-07-02 17:17 | 2026-07-01 | CYTK | Lee Sung | EVP, CFO | S - Sale+OE | $87.79 | -1,112 | 63.2K | -2% | -$97.6K |
| DMT | 2026-06-29 18:05 | 2026-06-24 | CYTK | Lee Sung | EVP, CFO | M - OptEx | $47.10 | +38.7K | 102.0K | +61% | +$1.82M |
| DT | 2026-06-29 18:05 | 2026-06-24 | CYTK | Lee Sung | EVP, CFO | S - Sale+OE | $82.30 | -38.7K | 63.2K | -38% | -$3.19M |
| DMT | 2026-06-29 17:23 | 2026-06-29 | CYTK | Lee Sung | EVP, CFO | M - OptEx | $45.83 | +3,134 | 66.4K | +5% | +$143.6K |
| DT | 2026-06-29 17:23 | 2026-06-29 | CYTK | Lee Sung | EVP, CFO | S - Sale+OE | $85.00 | -3,134 | 63.2K | -5% | -$266.4K |
| DT | 2026-06-23 17:41 | 2026-06-23 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-06-23 17:41 | 2026-06-23 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $79.51 | -3,500 | 153.9K | -2% | -$278.3K |
| T | 2026-06-15 16:40 | 2026-06-15 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale | $70.46 | -7,500 | 385.3K | -2% | -$528.5K |
| DT | 2026-06-09 17:40 | 2026-06-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-06-09 17:40 | 2026-06-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $67.98 | -3,500 | 153.9K | -2% | -$237.9K |
| T | 2026-06-01 18:54 | 2026-06-01 | CYTK | Kaye Edward M. MD | Dir | S - Sale | $76.09 | -2,933 | 10.3K | -22% | -$223.2K |
| DT | 2026-06-01 18:51 | 2026-06-01 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $23.26 | +15.0K | 73.6K | +26% | +$348.9K |
| DT | 2026-06-01 18:51 | 2026-06-01 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $74.08 | -15.0K | 58.6K | -20% | -$1.11M |
| T | 2026-06-01 18:49 | 2026-06-01 | CYTK | PARSHALL B LYNNE | Dir | S - Sale | $74.08 | -5,000 | 15.8K | -24% | -$370.4K |
| T | 2026-05-28 16:21 | 2026-05-27 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale | $77.21 | -7,500 | 392.8K | -2% | -$579.1K |
| D | 2026-05-27 19:16 | 2026-05-27 | CYTK | Bhanji Muna | Dir | A - Grant | $0.00 | +2,851 | 26.4K | +12% | $0 |
| D | 2026-05-27 19:14 | 2026-05-27 | CYTK | Daly James M | Dir | A - Grant | $0.00 | +2,851 | 3,239 | +735% | $0 |
| D | 2026-05-27 19:13 | 2026-05-27 | CYTK | Harrington Robert Arthur | Dir | A - Grant | $0.00 | +2,851 | 21.8K | +15% | $0 |
| D | 2026-05-27 19:12 | 2026-05-27 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $0.00 | +2,851 | 78.1K | +4% | $0 |
| D | 2026-05-27 19:11 | 2026-05-27 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $0.00 | +2,851 | 13.2K | +28% | $0 |
| D | 2026-05-27 19:10 | 2026-05-27 | CYTK | PARSHALL B LYNNE | Dir | A - Grant | $0.00 | +2,851 | 20.8K | +16% | $0 |
| D | 2026-05-27 19:09 | 2026-05-27 | CYTK | Landry Robert E | Dir | A - Grant | $0.00 | +2,851 | 10.2K | +39% | $0 |
| D | 2026-05-27 19:08 | 2026-05-27 | CYTK | WIERENGA WENDELL | Dir | A - Grant | $0.00 | +2,851 | 35.5K | +9% | $0 |
| D | 2026-05-27 19:07 | 2026-05-27 | CYTK | Wysenski Nancy | Dir | A - Grant | $0.00 | +2,851 | 33.9K | +9% | $0 |
| DT | 2026-05-20 16:00 | 2026-05-19 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-05-20 16:00 | 2026-05-19 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $75.69 | -3,500 | 153.9K | -2% | -$264.9K |
| T | 2026-05-14 16:26 | 2026-05-14 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale | $77.92 | -7,500 | 400.3K | -2% | -$584.4K |
| DT | 2026-05-05 17:35 | 2026-05-05 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-05-05 17:35 | 2026-05-05 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $77.37 | -3,500 | 153.9K | -2% | -$270.8K |
| DT | 2026-05-05 16:20 | 2026-05-05 | CYTK | WIERENGA WENDELL | Dir | M - OptEx | $12.40 | +4,032 | 36.7K | +12% | +$50.0K |
| DT | 2026-05-05 16:20 | 2026-05-05 | CYTK | WIERENGA WENDELL | Dir | S - Sale+OE | $75.00 | -4,032 | 32.6K | -11% | -$302.4K |
| T | 2026-05-05 16:18 | 2026-05-05 | CYTK | Lee Sung | EVP, CFO | S - Sale | $76.87 | -23.9K | 63.2K | -27% | -$1.84M |
| DT | 2026-05-05 16:15 | 2026-05-05 | CYTK | HENDERSON JOHN T | Dir | M - OptEx | $7.61 | +20.0K | 95.2K | +27% | +$152.2K |
| DT | 2026-05-05 16:15 | 2026-05-05 | CYTK | HENDERSON JOHN T | Dir | S - Sale+OE | $75.97 | -20.0K | 75.2K | -21% | -$1.52M |
| DT | 2026-05-05 16:11 | 2026-05-05 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $39.13 | +11.3K | 69.9K | +19% | +$443.5K |
| DT | 2026-05-05 16:11 | 2026-05-05 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $77.25 | -11.3K | 58.6K | -16% | -$875.5K |
| DT | 2026-05-04 16:01 | 2026-05-01 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $37.63 | +15.9K | 74.4K | +27% | +$596.7K |
| DT | 2026-05-04 16:01 | 2026-05-01 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $65.00 | -15.9K | 58.6K | -21% | -$1.03M |
| DT | 2026-04-30 16:22 | 2026-04-30 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $23.26 | +15.0K | 73.6K | +26% | +$348.9K |
| DT | 2026-04-30 16:22 | 2026-04-30 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $63.26 | -15.0K | 58.6K | -20% | -$948.9K |
| T | 2026-04-29 16:23 | 2026-04-29 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale | $59.62 | -7,500 | 407.8K | -2% | -$447.1K |
| DT | 2026-04-21 16:22 | 2026-04-21 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-04-21 16:22 | 2026-04-21 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $65.69 | -3,500 | 153.9K | -2% | -$229.9K |
| 2026-04-15 18:37 | 2026-04-15 | CYTK | Wysenski Nancy | Dir | A - Grant | $65.37 | +95 | 31.1K | +0.3% | +$6,210 | |
| 2026-04-15 18:36 | 2026-04-15 | CYTK | WIERENGA WENDELL | Dir | A - Grant | $65.37 | +95 | 32.6K | +0.3% | +$6,210 | |
| 2026-04-15 18:35 | 2026-04-15 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $65.37 | +191 | 10.4K | +2% | +$12.5K | |
| 2026-04-15 18:34 | 2026-04-15 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $65.37 | +325 | 75.2K | +0.4% | +$21.2K | |
| 2026-04-15 18:33 | 2026-04-15 | CYTK | Harrington Robert Arthur | Dir | A - Grant | $65.37 | +191 | 18.9K | +1% | +$12.5K | |
| 2026-04-15 18:32 | 2026-04-15 | CYTK | Daly James M | Dir | A - Grant | $65.37 | +191 | 388 | +97% | +$12.5K | |
| T | 2026-04-15 17:29 | 2026-04-15 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $66.02 | -7,449 | 58.6K | -11% | -$491.8K |
| T | 2026-04-15 17:27 | 2026-04-15 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale | $65.38 | -7,500 | 415.3K | -2% | -$490.3K |
| DMT | 2026-04-08 16:18 | 2026-04-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $8.42 | +4,500 | 154.9K | +3% | +$37.9K |
| DMT | 2026-04-08 16:18 | 2026-04-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $65.11 | -4,500 | 153.9K | -3% | -$293.0K |
| T | 2026-04-01 16:34 | 2026-04-01 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale | $66.63 | -7,500 | 422.8K | -2% | -$499.7K |
| 2026-03-31 | 2026-03-31 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $65.00 | -3,639 | 66.0K | -5% | -$236.5K | |
| 2026-03-18 | 2026-03-18 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $62.07 | -1,930 | 78.2K | -2% | -$119.8K | |
| M | 2026-03-18 | 2026-03-17 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $62.15 | -8,542 | 71.6K | -11% | -$530.9K |
| M | 2026-03-18 | 2026-03-17 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale | $62.15 | -36.6K | 430.3K | -8% | -$2.27M |
| M | 2026-03-18 | 2026-03-17 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $62.15 | -12.0K | 158.3K | -7% | -$747.9K |
| 2026-03-18 | 2026-03-17 | CYTK | Lee Sung | EVP, CFO | S - Sale | $62.15 | -4,935 | 87.1K | -5% | -$306.7K |
Purchase Sale Sale after option exercise All abbreviations